Ceftaroline desensitization procedure in a pregnant patient with multiple drug allergies
- PMID: 26034776
- PMCID: PMC4438906
- DOI: 10.1093/ofid/ofv027
Ceftaroline desensitization procedure in a pregnant patient with multiple drug allergies
Abstract
Validated skin testing is lacking for many drugs, including ceftaroline. The cross-reactivity between ceftaroline and other β-lactam antibiotics is unknown. We report a case of a pregnant patient with cystic fibrosis and multiple drug allergies who required ceftaroline for methicillin-resistant Staphylococcus aureus pneumonia and underwent an uncomplicated empiric desensitization procedure.
Keywords: ceftaroline; cross-reactivity; desensitization procedure; drug allergy; β-lactam.
Figures
References
-
- Kelly WN. Potential risks and prevention, part 1: fatal adverse drug events. Am J Health Syst Pharm 2001; 58:1317–24. - PubMed
-
- Lee CW, Matulonis UA, Castells MC. Carboplatin hypersensitivity: a 6-h 12-step protocol effective in 35 desensitizations in patients with gynecological malignancies and mast cell/IgE-mediated reactions. Gynecol Oncol 2004; 95:370–6. - PubMed
-
- Kelkar PS, Li JT. Cephalosporin allergy. N Engl J Med 2001; 345:804–9. - PubMed
-
- Drug allergy: an updated practice parameter. Ann Allergy Asthma Immunol 2010; 105:259–73. - PubMed
Grants and funding
LinkOut - more resources
Full Text Sources